{HEAD ~ The method} 9, wherein said oral administration is characterized by {TAIL ~ substantially no increase} in serum levels of aspartate aminotransferase , alanine aminotransferase , or both 
{ HEAD ~ The method } 9 , wherein said oral administration is characterized by { TAIL ~ substantially no increase } in serum levels of aspartate aminotransferase , alanine aminotransferase , or both
HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH